IRadimed CorporationIRMDNASDAQ

Revenue (LTM)

$84M

+14.4% YoY

Net Income (LTM)

$22M

+16.9% YoY

Free Cash Flow

$17M

Revenue CAGR (5Y)

+21.5%

—Marginsstable

FCF$0.0B

Profitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	42	53↑27.5%	66↑23.0%	73↑11.7%	84↑14.4%
Gross Profit	32	41↑28.8%	50↑21.5%	56↑12.3%	64↑14.2%
Operating Income	10	16↑59.2%	20↑28.2%	22↑9.6%	26↑19.0%
Net Income	9	13↑37.6%	17↑34.0%	19↑11.9%	22↑16.9%
EBITDA	11	16↑45.2%	21↑27.6%	23↑9.5%	29↑25.2%
EPS Diluted	0.74	1.02↑37.8%	1.35↑32.4%	1.50↑11.1%	1.75↑16.7%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	62	58↓6.5%	50↓14.1%	52↑5.0%	51↓2.1%
Total Current Assets	76	77↑1.6%	76↓1.9%	75↓1.0%	81↑7.9%
Total Assets	83	86↑3.2%	92↑7.8%	98↑6.7%	109↑10.6%
Total Current Liabilities	7	9↑25.4%	16↑90.9%	9↓47.9%	10↑19.6%
Total Liabilities	11	12↑10.6%	21↑75.1%	12↓44.5%	14↑23.0%
Total Equity	72	74↑2.1%	71↓3.1%	87↑21.6%	95↑9.0%
Total Debt	2	2↓11.2%	2↓7.4%	0↓92.4%	0
Net Debt	-60	-56↑6.3%	-48↑14.4%	-52↓9.1%	-51↑1.8%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	11	10↓10.8%	13↑34.1%	26↑90.3%	25↓2.6%
Capital Expenditure	-1	-2↓152.8%	-8↓327.0%	-8↑0.0%	-8↑3.0%
Free Cash Flow	11	8↓22.3%	5↓33.2%	18↑222.8%	17↓2.5%
Stock-Based Comp	1	1↓4.5%	2↑56.9%	3↑15.4%	3↑15.6%
Net Change in Cash	12	-4↓133.9%	-8↓103.0%	2↑130.1%	-1↓143.5%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance